Clinical trial

IDEAL Study: Identification of the Determinants of the Efficacy of Arterial…

NCT00128518 · Hospices Civils de Lyon, Other · Completed

Key facts

NCT number NCT00128518
Title IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Official title IDEAL Study : Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Lead sponsor Hospices Civils de Lyon, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hypertension
Intervention type Drug
Interventions Indapamide (T2), Perindopril (T1), Placebo of Perindopril (P1), Placebo of Indapamide (P2)
Enrollment 139
Start date Oct 1, 2004
Primary completion Sep 1, 2010
Completion Sep 1, 2010
First posted Aug 10, 2005
Last update posted Dec 19, 2025
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies